Multiple Isoforms of Beta-TrCP Display Differential Activities in the Regulation of Wnt Signaling

Overview

Journal Cell Signal

Date 2008 Oct 22

PMID 18929646

Citations 15

Authors

Eunjeong Seo

Hyunjoon Kim

Rokki Kim

Sangmoon Yun

Minseong Kim

Jin-Kwan Han

Frank Costantini

Eek-Hoon Jho

Affiliations

Soon will be listed here.

Abstract

The F-box proteins beta-TrCP1 and 2 (beta-transducin repeat containing protein) have 2 and 3 isoforms, respectively, due to alternative splicing of exons encoding the N-terminal region. We identified an extra exon in between the previously known exons 1 and 2 of beta-TrCP1 and beta-TrCP2. Interestingly, sequence analysis suggested that many more isoforms are produced than previously identified, via the alternative splicing of all possible combination of exons II to V of beta-TrCP1 and exons II to IV of beta-TrCP2. Different mouse tissues show specific expression patterns of the isoforms, and the level of expression of the isoform that has been used in most published papers was very low. Yeast two-hybrid assays show that beta-TrCP1 isoforms containing exon III, which are the most highly expressed isoforms in most tissues, do not interact with Skp1. Indirect immunofluorescence analysis of transiently expressed beta-TrCP1 isoforms suggests that the presence of exon III causes beta-TrCP1 to localize in nuclei. Consistent with the above findings, isoforms including exon III showed a reduced ability to block ectopic embryonic axes induced via injection of Wnt8 or beta-catenin in Xenopus embryos. Overall, our data suggest that isoforms of beta-TrCPs generated by alternative splicing may have different biological roles.

Citing Articles

The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives.

Qie S Cancers (Basel). 2022; 14(9).

PMID: 35565262 PMC: 9101129. DOI: 10.3390/cancers14092133.

F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Tekcham D, Chen D, Liu Y, Ling T, Zhang Y, Chen H Theranostics. 2020; 10(9):4150-4167.

PMID: 32226545 PMC: 7086354. DOI: 10.7150/thno.42735.

Controlling Nuclear NF-κB Dynamics by β-TrCP-Insights from a Computational Model.

Benary U, Wolf J Biomedicines. 2019; 7(2).

PMID: 31137887 PMC: 6631534. DOI: 10.3390/biomedicines7020040.

Two major alternative splice variants of beta-TrCP1 interact with CENP-W with different binding preferences.

Cheon Y, Lee S Genes Genomics. 2018; 41(2):167-174.

PMID: 30267325 DOI: 10.1007/s13258-018-0748-3.

GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression.

Zhu Y, Zhou Q, Zhu G, Xing Y, Li S, Ren N Oncotarget. 2017; 8(51):88599-88612.

PMID: 29179460 PMC: 5687630. DOI: 10.18632/oncotarget.20100.

References

Caceres J, Kornblihtt A . Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 2002; 18(4):186-93. DOI: 10.1016/s0168-9525(01)02626-9. View

Spiegelman V, Slaga T, Pagano M, Minamoto T, Ronai Z, Fuchs S . Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol Cell. 2000; 5(5):877-82. DOI: 10.1016/s1097-2765(00)80327-5. View

Margottin-Goguet F, Hsu J, Loktev A, Hsieh H, Reimann J, Jackson P . Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell. 2003; 4(6):813-26. DOI: 10.1016/s1534-5807(03)00153-9. View

Fuchs S, Spiegelman V, Kumar K . The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene. 2004; 23(11):2028-36. DOI: 10.1038/sj.onc.1207389. View

Lassot I, Segeral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T . ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase. Mol Cell Biol. 2001; 21(6):2192-202. PMC: 86853. DOI: 10.1128/MCB.21.6.2192-2202.2001. View

Bour S, Perrin C, Akari H, Strebel K . The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J Biol Chem. 2001; 276(19):15920-8. DOI: 10.1074/jbc.M010533200. View

Ganiatsas S, Dow R, Thompson A, SCHULMAN B, Germain D . A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT. Oncogene. 2001; 20(28):3641-50. DOI: 10.1038/sj.onc.1204501. View

Spiegelman V, Stavropoulos P, Latres E, Pagano M, Ronai Z, Slaga T . Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB. J Biol Chem. 2001; 276(29):27152-8. DOI: 10.1074/jbc.M100031200. View

Ballarino M, Marchioni M, Carnevali F . The Xenopus laevis beta TrCP gene: genomic organization, alternative splicing, 5' and 3' region characterization and comparison of its structure with that of human beta TrCP genes. Biochim Biophys Acta. 2002; 1577(1):81-92. DOI: 10.1016/s0167-4781(02)00416-5. View

10.

Watanabe N, Arai H, Nishihara Y, Taniguchi M, Watanabe N, Hunter T . M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc Natl Acad Sci U S A. 2004; 101(13):4419-24. PMC: 384762. DOI: 10.1073/pnas.0307700101. View

11.

Welcker M, Orian A, Grim J, Grim J, Eisenman R, Clurman B . A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol. 2004; 14(20):1852-7. DOI: 10.1016/j.cub.2004.09.083. View

12.

Neer E, Schmidt C, Nambudripad R, Smith T . The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994; 371(6495):297-300. DOI: 10.1038/371297a0. View

13.

Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper J . SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 1996; 86(2):263-74. DOI: 10.1016/s0092-8674(00)80098-7. View

14.

Aberle H, Bauer A, Stappert J, Kispert A, Kemler R . beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997; 16(13):3797-804. PMC: 1170003. DOI: 10.1093/emboj/16.13.3797. View

15.

Patton E, Willems A, Tyers M . Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet. 1998; 14(6):236-43. DOI: 10.1016/s0168-9525(98)01473-5. View

16.

Margottin F, Bour S, Durand H, Selig L, Benichou S, Richard V . A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell. 1998; 1(4):565-74. DOI: 10.1016/s1097-2765(00)80056-8. View

17.

Michel J, Xiong Y . Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ. 1998; 9(6):435-49. View

18.

Winston J, Strack P, Chu C, Elledge S, Harper J . The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999; 13(3):270-83. PMC: 316433. DOI: 10.1101/gad.13.3.270. View

19.

Maniatis T . A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev. 1999; 13(5):505-10. DOI: 10.1101/gad.13.5.505. View

20.

Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet J . Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP. J Biol Chem. 1999; 274(12):7941-5. DOI: 10.1074/jbc.274.12.7941. View